Multicenter, multi-site study on the prevalence and determinants of practices that increase the risk of HIV and HCV transmission among people who use drugs (Coquelicot Study). Feasibility phase – January 2001–September 2002. Final report

This report provides a detailed account of the steps involved in setting up and conducting a pilot study of drug users carried out between January 2001 and June 2002 in the city of Marseille. This study first sought to determine the feasibility of a larger-scale cross-sectional data collection (multi-city, multi-site) whose scientific objectives were to describe the characteristics, needs, and risk-taking behaviors of drug users, and to measure the prevalence and incidence of HIV and HCV using biological samples (saliva or blood) within this population. This feasibility phase also provided epidemiological and biological data on a sample of 166 individuals, the analysis of which is included in the report.

Author(s): Emmanuelli J, Jauffret Roustide M, Desenclos JC, Laporte A, Arduin P, Quaglia M

Publishing year: 2003

Pages: 80 p.

In relation to

Our latest news

news

2026 “Sexual Behavior” Survey (ERAS) for men who have sex with men

news

Hervé Maisonneuve has been appointed scientific integrity officer for a...

Visuel illustratif

news

Public Health France 2026 Barometer: Launch of the Survey